Al Mayadeen English

  • Ar
  • Es
  • x
Al Mayadeen English

Slogan

  • News
    • Politics
    • Economy
    • Sports
    • Arts&Culture
    • Health
    • Miscellaneous
    • Technology
    • Environment
  • Articles
    • Opinion
    • Analysis
    • Blog
    • Features
  • Videos
    • NewsFeed
    • Video Features
    • Explainers
    • TV
    • Digital Series
  • Infographs
  • In Pictures
  • • LIVE
News
  • Politics
  • Economy
  • Sports
  • Arts&Culture
  • Health
  • Miscellaneous
  • Technology
  • Environment
Articles
  • Opinion
  • Analysis
  • Blog
  • Features
Videos
  • NewsFeed
  • Video Features
  • Explainers
  • TV
  • Digital Series
Infographs
In Pictures
  • Africa
  • Asia
  • Asia-Pacific
  • Europe
  • Latin America
  • MENA
  • Palestine
  • US & Canada
BREAKING
Sheikh Qassem: Resistance is a source of power for Lebanon that must be preserved.
Sheikh Qassem: "Israel" must implement the agreement as Lebanon has already done so, and any new accord would amount to absolving it and opening the door to further attacks.
Sheikh Qassem: We do not wish to assume anyone's role; those accusing us of this must cease their accusations.
Sheikh Qassem: We will recover our lands through national solidarity; Resistance's goal is national liberation, while enemy goal is occupation.
Sheikh Qassem: Protection of sovereignty protects Lebanon. It is in real danger because of US belligerence, greedy Israeli expansion.
Qassem to Lebanese people: We are not asking for support but for us not to be stabbed in the back in the back or for some to serve Israeli interests; government is primary party responsible for [preservation of] sovereignty.
Sheikh Qassem: "Israel" can occupy, but it cannot persist in occupation of our land.
Sheikh Qassem: Intimidation will not change our stance of resistance and steadfastness. We are not advocates of surrender or defeat, and we will never accept it.
Sheikh Qassem: Where does US stand regarding enemy's unjustified assassination of a government worker and other civilian martyrs?
Sheikh Qassem: Is the Lebanese Army's defense of its land and citizens an accusation [leveled against it]? Where does US stand regarding the enemy's killing of civilians and constant destruction?

Study finds Ozempic good for the heart, not just weight loss

  • By Al Mayadeen English
  • Source: News websites
  • 25 Aug 2023 18:21
3 Min Read

One year-long study spanning 13 countries shows that Ozempic has helped in improving the quality of life of heart failure patients.

  • x
  • The anti-diabetic medication Ozempic (semaglutide) made by Danish pharmaceutical company Novo Nordisk. (AFP)
    The anti-diabetic medication Ozempic (Semaglutide) was made by the Danish pharmaceutical company Novo Nordisk. (AFP)

Semaglutide jabs being used as weight loss drugs are now reported to have a great impact on the heart, according to a global study that is the first of its kind.

As heart failure is one of the world's most growing threats to health, with about 65 million people suffering from the condition and a few treatment options available, the fact that a drug like Ssemaglutide, which is usually sold under the names Ozempic, Wegovy, and Rybelsus, can trigger "very large improvements" across a wide range of symptoms may be game-changing.

Read more: Weight loss drug on TikTok, Ozempic, raises concerns among doctors

"We are talking about marked improvements in symptoms such as shortness of breath, fatigue, inability to have physical exertion, swelling," said the lead author of the study, Dr. Mikhail Kosiborod, a cardiologist and vice-president for research at Saint Luke’s Mid America Heart Institute in Kansas City, Missouri. "These types of improvements can be very impactful for patients living with heart failure."

The study's findings were revealed on the first day of the world's largest heart conference, in the European Society of Cardiology's annual meeting, and was lauded by experts who said it could leave a "transformational impact" on the lives of millions.

Related News

Weight-loss drug cuts risk of heart attack, strokes: Novo Nordisk

BMI metric has caused 'historical harm': AMA

During the study, researchers used Semaglutide to treat heart failure patients suffering from stiff heart pumps. The trial included 529 patients from 13 countries in four continents. All patients involved had a BMI of over 30, with a median age of 69 and a median weight of 105.1kg.

One group was given a weekly dose of 2.4mg of semaglutide for a year, while the other was given a placebo. The study looked at changes in body weight, symptoms related to heart failure, and whether or not patients were able to perform better at walking for six minutes, and results were markedly better for patients who received the Semaglutide jabs, with body weight being reduced by a mean of 13.3% in the jab group, in contrast to the 2.6% of the placebo group.

"These findings are impressive and impactful. The benefits we observed with semaglutide versus placebo on these very important outcomes for patients with this type of heart failure – their symptoms and physical function – are the largest that we have ever seen with any pharmacologic intervention in this patient population," Kosiborod said.

The medication "produced large improvements in symptoms, physical limitations and exercise function, reduced inflammation, and resulted in greater weight loss and fewer serious adverse events as compared with placebo".

"This study demonstrates that semaglutide is not only safe for people with this type of heart failure but it also has important benefits for their quality of life," according to Dr. Sonya Babu-Narayan, associate medical director at the British Heart Foundation.

"For some people, living with heart failure can make everyday activities difficult or even impossible. The kind of improvements seen in this study, such as being able to walk further, could have a transformational impact on someone’s life."

Disclaimer: Please consult your physician before taking any drug.

  • overweight
  • heart disease
  • ozempic
  • heart failure

Most Read

Arab League chief exposes secret US deal shielding 'Israel’s' nukes

Arab League chief exposes secret US deal shielding 'Israel’s' nukes

  • Politics
  • 27 Oct 2025
Hi-tech holocaust: Microsoft’s role in Gaza genocide

Microsoft's role in world’s first AI-driven genocide, in Gaza, exposed

  • Technology
  • 28 Oct 2025
Sheikh Naim Qassem speaks during an interview with Al-Manar TV, October 26, 2025 (Screenshot)

Hezbollah ready to face 'Israel' in case of war: Sheikh Naim Qassem

  • Politics
  • 27 Oct 2025
The secret cloud deal: Google and Amazon “winking” pact with 'Israel'

With a 'wink', Israeli control over Google, Amazon cloud data exposed

  • Technology
  • 29 Oct 2025

Coverage

All
War on Gaza

Read Next

All
ap
Politics

Hamas calls on int’l community to act against Israeli settlement plan

In this Nov. 9, 2017, file photo, U.S. President Donald Trump, right, chats with Chinese President Xi Jinping during a welcome ceremony at the Great Hall of the People in Beijing. (AP)
Economy

Ex-US diplomat says Trump-Xi deal 'tactical retreat', not lasting deal

An unarmed Minuteman II intercontinental ballistic missile launches from Vandenberg Air Force Base, California, during a test in 2002. (US Air Force)
Politics

JD Vance defends Trump's nuclear test plan as 'crucial for security'

Ultra-Orthodox Jews attend the "million man" protest against military conscription, in occupied al-Quds, October 30, 2025 (AFP)
Politics

Haredi mass rally in al-Quds exposes Zionist regime's growing crisis

Al Mayadeen English

Al Mayadeen is an Arab Independent Media Satellite Channel.

All Rights Reserved

  • x
  • Privacy Policy
  • About Us
  • Contact Us
  • Authors
Android
iOS